Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06142552 |
| Consolidated Lead Sponsor | Hangzhou Gensciences Biopharmaceutical Co |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 124 participants (ACTUAL) |
| Registered Start Date | 2023-12-27 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, China | Open Hospital Dossier -> |
| Fujian Medical University Union Hospital | Fuzhou, China | Open Hospital Dossier -> |
| Nanfang Hospital of Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.